HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
26 hedge funds and large institutions have $5.6M invested in Hepion Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
26
Holding in Top 10
–
Calls
$144K
Puts
–
Top Buyers
| 1 | +$45.7K | |
| 2 | +$29.6K | |
| 3 | +$25.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.8K |
Top Sellers
| 1 | -$35.7K | |
| 2 | -$15.3K | |
| 3 | -$8.63K | |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$7.67K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$5.48K |